@Article{Wierz­bow­ska2005,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="107",
number="2",
year="2005",
title="Miej­sce ana­lo­gów pro­sta­glan­dyn w far­ma­ko­te­ra­pii ja­skry – stan obec­ny",
abstract="Therapy with prostaglandin analogues (PGA), a novel class of intraocular-lowering medications, represents a safe and very effective pharmacologic method of treating patients with glaucoma and ocular hypertension. The convince dosing regimen, once-daily, higher efficacy and higher systemic safety profile seen with PGA compared with betablockers caused that these agents have been approved by regulatory bodies for both the first-line and adjunctive therapy. Short, retrospective analysis of the medical treatment of glaucoma in the Ophthalmology Clinic of Military Health Service Institute in Warsaw, in 2003-2004, was presented.",
author="Wierz­bow­ska, Jo­an­na
and Rękas, Marek
and Ma­law­ko, Da­ria",
pages="312--315",
url="https://www.termedia.pl/The-pre-sent-ro-le-of-pro-sta-glan-din-ana-lo-gu-es-in-the-me-di-cal-tre-at-ment-of-glau-co-ma,124,49655,1,1.html"
}